Target intelligence / Profile preview

Other system L and non-system A amino acid transporters

Molecular classification
Transporter, Solute carrier (SLC) family
01

Overview

Other system L and non-system A amino acid transporters refers to a functional grouping of solute carrier (SLC) proteins that facilitate the transport of neutral and basic amino acids across cellular membranes, excluding the primary System A transporters (SNAT1, SNAT2, and SNAT4). This category typically encompasses System L isoforms other than the well-characterized LAT1, such as LAT2 (SLC7A8), LAT3 (SLC43A1), and LAT4 (SLC43A2), as well as other transporters like System N (SLC38A3/5) and System B0,+ (SLC6A14). These transporters are essential for maintaining cellular nutrient homeostasis and are frequently upregulated in various cancers to support the high metabolic demands of tumor growth. In pharmacological research, this group is often defined by its sensitivity to the inhibitor 2-aminobicyclo[2.2.1]heptane-2-carboxylic acid (BCH) and its lack of inhibition by System A-selective agents like MeAIB. While they serve as critical pathways for the delivery of amino acid-based drugs and imaging tracers, their broad expression across essential tissues like the blood-brain barrier and kidneys presents challenges for achieving high therapeutic selectivity.

Other names
Non-system A amino acid transportersOther system L transportersBCH-sensitive amino acid transportersSystem L and non-system A transporters
02

Mechanism of action

Amino acid transporter inhibitor, Amino acid transporter substrate

03

Biological functions

Amino acid transportNutrient uptakeMetabolic regulationCell growth and proliferationNeurotransmitter precursor supplymTOR signaling activation
04

Disease associations

CancerNeurodegenerative diseaseMetabolic disorderAminoaciduria
05

Safety considerations

Interference with essential amino acid homeostasisPotential for systemic toxicity due to ubiquitous expressionOff-target effects at the blood-brain barrierCompetition with endogenous amino acids for transport
06

Interacting drugs

2-aminobicyclo[2.2.1]heptane-2-carboxylic acid (BCH)

4 more in the full profile.

07

Biomarkers

SLC7A8 (LAT2) expression levelSLC43A1 (LAT3) expression levelSLC43A2 (LAT4) expression levelO-(2-[18F]fluoroethyl)-L-tyrosine (FET) uptakeL-[methyl-11C]methionine (MET) uptake

Beyond the preview

Go deeper on Other system L and non-system A amino acid transporters.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Other system L and non-system A amino acid transporters.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call